Ongoing research and larger patient registries will be crucial for elucidating the full spectrum of genotype–phenotype correlations, as well as developing tailored therapeutic approaches for TMEM38B-related OI. The gene discussed is TMEM38B; the disease is osteogenesis imperfecta.